0
Signin
countryflagUS

18889881171

MSFT 417.14 0.9731% AAPL 229.0 -0.3438% NVDA 119.37 1.5137% GOOGL 163.38 0.989% GOOG 165.11 1.0465% AMZN 178.5 3.7067% META 521.31 0.5963% AVGO 162.82 3.7533% TSLA 214.11 3.7958% TSM 171.7 1.5075% LLY 960.02 2.1081% V 276.37 0.7473% JPM 224.8 1.1656% UNH 590.2 -0.2316% NVO 139.16 1.1926% WMT 77.23 1.0599% LVMUY 149.005 -0.3844% XOM 117.94 -0.1608% LVMHF 745.0 -0.4011% MA 483.34 0.5283%

Sona Nanotech Inc

Healthcare US SNANF

0.215USD
-(-%)

Last update at 2024-08-30T13:30:00Z

Day Range

0.210.21
LowHigh

52 Week Range

0.050.26
LowHigh

Fundamentals

  • Previous Close 0.21
  • Market Cap18.78M
  • Volume0
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-0.68096M
  • Revenue TTM0.00000M
  • Revenue Per Share TTM-
  • Gross Profit TTM 0.00000M
  • Diluted EPS TTM-

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-10-31 2021-10-31 2020-10-31 2019-10-31 2018-10-31
Type yearly yearly yearly yearly yearly
Date 2022-10-31 2021-10-31 2020-10-31 2019-10-31 2018-10-31
Income before tax -2.36140M -10.36722M -6.27202M -2.52071M -5.19633M
Minority interest - - - - -
Net income -2.36140M -10.36722M -6.27202M -2.52071M -5.19633M
Selling general administrative 2.99M 10.54M 5.51M 1.63M 5.06M
Selling and marketing expenses - - - - -
Gross profit - - - - -
Reconciled depreciation 0.06M 0.07M 0.07M 0.05M 0.03M
Ebit -3.01679M -10.67056M -5.95415M -1.65606M -1.13580M
Ebitda -2.21678M -10.28078M -6.18009M -2.32402M -5.09294M
Depreciation and amortization - - - - -
Non operating income net other - - - - -
Operating income -3.13616M -10.73179M -9.13097M -1.65606M -5.18103M
Other operating expenses - - - - -
Interest expense 0.08M 0.02M 0.03M 0.15M 0.08M
Tax provision - - - - -
Interest income - - - - -
Net interest income -0.08431M -0.02085M -0.02556M -0.14558M -0.07558M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense - - - - -
Total revenue 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Total operating expenses 3.14M 10.73M 9.13M 1.66M 5.18M
Cost of revenue - - - - -
Total other income expense net 0.86M 0.39M 2.88M -0.71907M 0.06M
Discontinued operations - - - - -
Net income from continuing ops -2.36140M -10.36722M -6.27202M -2.52071M -5.19633M
Net income applicable to common shares -2.36140M -10.36722M -6.27202M -2.52171M -5.19633M
Preferred stock and other adjustments - - - - -
Breakdown 2022-10-31 2021-10-31 2020-10-31 2019-10-31 2018-10-31
Type yearly yearly yearly yearly yearly
Date 2022-10-31 2021-10-31 2020-10-31 2019-10-31 2018-10-31
Total assets 0.52M 1.52M 0.72M 0.86M 3.18M
Intangible assets - - - - -
Earning assets - - - - -
Other current assets - - - - -
Total liab 1.03M 2.75M 4.16M 1.88M 2.98M
Total stockholder equity -0.50786M -1.22337M -3.43547M -1.02244M 0.20M
Deferred long term liab - - - - -
Other current liab 0.09M 0.83M 0.60M 0.00950M 0.42M
Common stock 14.32M 12.68M 8.85M 7.83M 6.74M
Capital stock 14.32M 12.68M 8.85M 7.82M 6.74M
Retained earnings -19.50683M -25.99145M -15.62423M -9.35220M -6.82850M
Other liab - - - - -
Good will - - - - -
Other assets - - - - -
Cash 0.16M 1.18M 0.10M 0.58M 1.80M
Cash and equivalents - - - - -
Total current liabilities 0.42M 2.05M 4.16M 1.21M 2.44M
Current deferred revenue - - - - -
Net debt 0.45M 0.15M 1.39M 0.58M -
Short term debt - - - 0.50M 0.55M
Short long term debt - 0.64M 1.49M 0.50M 0.55M
Short long term debt total - - - - -
Other stockholder equity 0.57M 0.57M - 0.17M 0.18M
Property plant equipment 0.05M 0.11M 0.18M 0.24M 1.08M
Total current assets 0.47M 1.41M 0.55M 0.62M 2.10M
Long term investments - - - - -
Net tangible assets -0.50786M -1.22337M -3.43547M -1.02244M 0.20M
Short term investments 0.00900M 0.01M 0.00800M 0.00450M 0.00550M
Net receivables 0.25M 0.13M 0.42M 0.02M 0.28M
Long term debt 0.61M 0.70M - 0.67M 0.54M
Inventory - - - - -
Accounts payable 0.33M 0.58M 2.07M 0.42M 0.73M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - - 0.24M 1.08M
Deferred long term asset charges - - - - -
Non current assets total 0.05M 0.11M 0.18M 0.24M 1.08M
Capital lease obligations - - - - -
Long term debt total - - - - -
Breakdown 2022-10-31 2021-10-31 2020-10-31 2019-10-31 2018-10-31
Type yearly yearly yearly yearly yearly
Date 2022-10-31 2021-10-31 2020-10-31 2019-10-31 2018-10-31
Investments - - -0.69402M -0.15873M -0.14569M
Change to liabilities -0.03089M -1.25669M 1.96M -0.25789M -0.30987M
Total cashflows from investing activities - - -0.69402M -0.15873M -0.14569M
Net borrowings - 0.10M 0.50M 0.26M 0.45M
Total cash from financing activities 0.78M 4.89M 4.27M 0.30M 3.33M
Change to operating activities - - - - -
Net income -2.36140M -10.36722M -6.27202M -2.52171M -5.19633M
Change in cash -1.02784M 1.08M -0.47787M -1.22289M 1.63M
Begin period cash flow 1.18M 0.10M 0.58M 1.80M 0.17M
End period cash flow 0.16M 1.18M 0.10M 0.58M 1.80M
Total cash from operating activities -1.80540M -3.81334M -4.05464M -1.36280M -1.55477M
Issuance of capital stock 0.00000M 2.25M - 0.00000M 2.44M
Depreciation 0.06M 0.07M 0.07M 0.05M 0.03M
Other cashflows from investing activities - - - - -
Dividends paid - - - - -
Change to inventory - - - - -
Change to account receivables -0.07584M -0.13940M -0.04371M 0.26M -0.13682M
Sale purchase of stock - - - - -
Other cashflows from financing activities 0.18M 0.74M 3.51M 3.51M 0.45M
Change to netincome 0.60M 7.88M 0.23M 1.11M 0.02M
Capital expenditures 0.00000M 0.00000M 0.38M 0.16M 0.15M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -0.10673M -1.39609M 1.92M 0.00026M -0.44669M
Stock based compensation 1.47M 8.24M 3.09M 0.24M -
Other non cash items -0.46012M -0.35201M -2.85544M -0.04850M 4.22M
Free cash flow -1.80540M -3.81334M -4.74866M -1.52153M -1.53713M

Peer Comparison

Sector: Healthcare Industry: Diagnostics & Research

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to EBITDA (x)
SNANF
Sona Nanotech Inc		 - -% 0.21 - - - 11.69 -33.1647
TMO
Thermo Fisher Scientific Inc		 3.39 0.55% 615.07 34.71 23.87 4.62 4.43 5.29 20.89
DHR
Danaher Corporation		 2.29 0.86% 269.31 29.09 28.01 5.67 3.20 6.00 19.09
IDXX
IDEXX Laboratories Inc		 -5.95 1.22% 481.33 49.99 45.66 11.29 27.85 11.46 34.46
IQV
IQVIA Holdings Inc		 0.76 0.30% 251.55 37.82 19.68 2.76 7.20 3.61 17.03

Reports Covered

Stock Research & News

View All

Profile

Sona Nanotech Inc., a nanotechnology life sciences company, engages in developing various rapid diagnostic tests. Its products and services include COVID-19 Saliva Lateral Flow Assay, an immunochromatographic assay for the detection of the spike protein antigen from SARS-CoV-2 in saliva specimens from individuals, who are suspected of COVID-19; Gemini gold nanorods; and contract services. The company is also involved in developing pre-clinical targeted hyperthermia therapy for colorectal cancer. Sona Nanotech Inc. was founded in 2014 and is based in Halifax, Canada.

Sona Nanotech Inc

Purdy?s Wharf Tower II, Halifax, NS, Canada, B3J 3R7

Key Executives

Name Title Year Born
Mr. David A. Regan Chief Exec. Officer NA
Mr. Darren Rowles Pres & Chief Scientific Officer 1980
Mr. Robert William George Randall CFO & Corp. Sec. 1963
Dr. Kulbir Singh Co-Founder & Head of R&D NA
Dr. Mike McAlduff Director of R&D & Production and Founder NA
Dr. Gerrard Marangoni Co-Founder & Member of Scientific Advisory Board NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.